Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in active ankylosing spondylitis
NCT01786668Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of tofacitinib oral solution in ankylosing spondylitis (AS), sponsored by Pfizer. Started Apr 2013; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01786668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786668.